Abstract
Chronic stressful occurrences are documented as a vital cause of both depression and anxiety disorders. However, the stress-induced molecular mechanisms underlying the common and distinct pathophysiology of these disorders remains largely unclear. We utilized a chronic mild stress (CMS) rat model to differentiate and subgroup depression-susceptible, anxiety-susceptible, and insusceptible rats. The hippocampus was analyzed for differential proteomes by combining mass spectrometry and the isobaric tags for relative and absolute quantitation (iTRAQ) labeling technique. Out of 2593 quantified proteins, 367 were aberrantly expressed. These hippocampal protein candidates might be associated with susceptibility to stress-induced depression or anxiety and stress resilience. They provide the potential protein systems involved in various metabolic pathways as novel investigative protein targets. Further, independent immunoblot analysis identified changes in Por, Idh2 and Esd; Glo1, G6pdx, Aldh2, and Dld; Dlat, Ogdhl, Anxal, Tpp2, and Sdha that were specifically associated to depression-susceptible, anxiety-susceptible, or insusceptible groups respectively, suggesting that identical CMS differently impacted the mitochondrial and metabolic processes in the hippocampus. Collectively, the observed alterations to protein abundance profiles of the hippocampus provided significant and novel insights into the stress regulation mechanism in a CMS rat model. This might serve as the molecular basis for further studies that would contributed to a better understanding of the similarities and differences in pathophysiologic mechanisms underlying stress-induced depression or anxiety, and stress resiliency.
Similar content being viewed by others
Introduction
Anxiety and depression are two major debilitating and prevalent psychiatric disorders affecting people of all ages1,2,3. Available research indicates that these two disorders share several putative risk factors, such as severe or stressful events in life and chronic stress4,5,6. Chronic stressful life events are among the environmental factors with a substantial adverse impact on the etiology of depression and anxiety disorders7,8. Extreme or sustained exposure to stress often perturbs the individual’s physiological and psychological functioning, leading to a variety of mood- and psychiatry-related disorders mainly including depression and anxiety7,8. To model some of the environmental factors affecting humans, the chronic mild stress (CMS) paradigm was developed to induce depression- and anxiety-related behaviors in rodents7,9,10. During exposure to CMS, some individuals engage in passive coping behaviors that promote vulnerability to depression and anxiety. Other individuals actively cope with deleterious effects of stress and display resiliency to these disorders9,10. The neural substrates underlying vulnerability or resilience to CMS-induced disorders are believed to be meaningful in elucidating the potential biological etiology and pathophysiology of these disorders11.
Clinically, depression and anxiety disorders exhibit different core symptoms but frequently coexist12,13. In view of considerable comorbidity and pathophysiological overlap of depression and anxiety, recent studies have begun to separately examine non-comorbid subjects with these two disorders in order to unravel common and specific features in the neural systems14,15,16,17. Depression and anxiety are often marked by memory loss and cognitive impairment, suggesting hippocampal neuronal dysfunction in the pathophysiology of these two disorders18. The hippocampus is among the most highly sensitive and malleable brain regions to stress stimulation19. Brain imaging data of the hippocampus in patients and stress-induced animal models with either depression or anxiety disorders indicated a remarkable reduction in region volume and dendritic spine numbers20,21. Potentially underlying these structural anomalies, chronic stress has been shown to have detrimental effects on hippocampal neurogenesis and neuroplasticity in these individuals6,22, consequently leading to cognitive and emotional symptoms of depression and anxiety23. Though hippocampal morphological and functional plasticity in both the depressed and the anxious individuals is aberrant24, the inherent content and extent of the changes may be substantially different and so far remain obscure. Correspondingly, the molecular regulatory processes linking to the development and maintenance of these disorders remain largely unclear25. Thus, there is a pressing need to identify common and distinct molecular characteristics that underlie susceptibility and resilience to depression or anxiety14.
It’s well known that proteins are the main executors of physiological function in organisms26, and thus their quantitative data/analysis can help enhance our understanding of pathophysiological mechanisms. Proteomics, as an unbiased quantitative tool of protein expression, has been frequently applied to identify a series of significant pathophysiological changes27. Moreover, proteomics aids in detecting novel signaling networks that are not easily identified by direct biochemical methods for target identification. We implemented an isobaric tags for relative and absolute quantitation (iTRAQ) based quantitative proteomics approach to explore common and distinct hippocampal protein features associated with depression and anxiety phenotypes in the CMS rat model. This model demarcates depression-susceptible, anxiety-susceptible, and insusceptible subpopulations, representing the three different responses to CMS. Subsequent proteomics analysis revealed several protein changes correlated with characteristics of maladaptive behavior of depression or anxiety disorders as well as adaptive behavior. Our findings provide a critical knowledge base of the common and unique molecular mechanisms underlying stress-induced depression and anxiety, and stress resiliency.
Materials and methods
Animal subjects
The Animal Facility of Chongqing Medical University, China provided male Sprague–Dawley rats weighing about 250 g each. They were exposed to a 12 h light/dark cycle at 55 ± 5% humidity and 21–22 °C temperatures with a standard rodent diet and tap water available ad libitum. The National Institutes of Health Guidelines for the Care and Use of Laboratory Animals were followed and the Ethics Committee of Chongqing Medical University approved this study’s protocol. Moreover, all rats were monitored on a daily basis.
CMS procedure
All rats were single-housed and permitted one week to acclimatize. For sucrose habituation, they were provided water and 1% sucrose solution for two weeks. According to the final three baseline tests of sucrose intakes, the rats were randomly divided into stressed and unstressed groups. The stressed group was exposed to an 8-week CMS procedure as described in Supplementary Table S128. Stressors were applied to induce depression-like and anxiety-like behaviors and included the following: paired housing, a 45° cage tilt, a soiled cage, white noise, water deprivation, an empty water bottle, strobe light, and continuous lighting. In contrast with water deprivation, or the absence of a water bottle, animals given their empty water bottles retain the behavior of water intake.
Sucrose preference test (SPT) and body weight
The SPT was employed to assess depression-like behavior (anhedonia) of rats. SPT was conducted according to the method described previously10. Briefly, during a no-stress period of 24 h, all rats had access to a choice of drinking bottles, one with water and one with 1% sucrose solution. The location of two drinking bottles was alternated arbitrarily between the left and right sides of each cage. The two bottles were weighed before and after testing to measure fluid consumption. Preference for sucrose was calculated using the formula: % sucrose preference = (sucrose intake/total fluid intake) × 100. Prior to the CMS procedure, the body weights of rats were recorded and taken weekly during the CMS period.
Forced swimming test (FST)
The depression-like behavior (behavioral despair) of rats was assessed with a FST. The test was performed over two sessions as described previously10. The rats were placed individually into Plexiglas cylinders of 40 cm in height, and 20 cm in diameter, that were filled with water (temperature 24 °C, height 30 cm), and given a pre-exposure to swimming for 5-min to confirm rapid adoption of an immobile posture. After 24 h of the rats were re-placed into the cylinder for 5 min. A trained observer blinded to group recorded the total immobility time. This test was real-time monitored with a video surveillance system.
Elevated plus maze test (EMT)
EMT is used to assess anxiety-like behavior of rats, as described previously7,29. The elevated plus maze room comprised of two open/close arms designed in a cross-shape. An open central square area of 5 × 5 cm in the arms joined to enable the rats to easily enter both arms of the maze. The rats freely explored the maze for 5 min after placing them onto the open square area, facing an open arm of the maize. We measured the time each rat spent in the open arms, the number of times they entered the open arms and the distance they traveled in each arm.
Tissue collection and protein extraction
Post behavior test, the rats were decapitated and their brain was immediately removed. The hippocampus tissues were extracted bilaterally and quickly frozen in liquid nitrogen and stored at −80 °C. For protein extraction, the hippocampus tissues were homogenized in SDT buffer (150 mM Tris–HCl, pH 8.0, 4% SDS, 100 mM dithiothreitol, containing a protease inhibitor cocktail). These extracts were boiled for 5 min and centrifuged for 15 min at 40,000 × g. The protein concentrations in the supernatant were measured by bicinchoninic acid assay (Pierce, USA).
Protein digestion
Sixty micrograms of protein lysates from each sample were separated via short gel electrophoresis. As described previously28,30, electrophoresis was conducted on a vertical polyacrylamide slab gel consisting of a staking layer of 4%, a separation layer of 10% about 1-cm-long, and a 50% interception layer. A 3.3% of N, N’-methylene bis-acrylamide was used as a cross-linker. Post electrophoresis and staining, each lane was excised and further sheared into four small portions and placed in a tube. In preparation for mass spectrometry (MS), gel digestion of the protein was carried out as previously described28,30. The gel slices were de-stained with 50% acetonitrile (ACN) in 50 mM NH4HCO3. After protein reduction and alkylation, the gels were washed several times in H2O and 50% ACN. The gel slices were dehydrated with 100% ACN and dried in a Speed Vac. They were re-hydrated with 200 mM triethylammonium bicarbonate containing 0.01 µg/µL trypsin (Promega, USA) and then underwent overnight incubation at 37 °C. The tryptic peptides were extracted using sonication in 67% ACN containing 2% formic acid. Subsequently the collected samples were dried for iTRAQ labeling.
Eight-plex iTRAQ labeling and strong cation exchange (SCX) fractionation
Tryptic peptides from the in-gel digestion were labeled with iTRAQ eight-plex reagents as previously described10,28. Eight samples, each obtained from two rats for the control, depression-susceptible, anxiety-susceptible, and insusceptible groups were labeled with reagents 113–121. They were pooled and then fractionated by offline SCX chromatography strategies, where the peptides underwent fractionation via gradient elution with SCX buffer (25% ACN, 10 mM KH2PO4, 500 mM KCl, pH 3.0), at 1-ml/min flow rate. The obtained fractions were pooled into 10 groups, desalted, vacuum-dried, and reconstituted with 0.1% formic acid in preparation for MS analysis.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
The peptides in the fractions were detected by use of AB SCIEX TripleTOF 5600 + mass spectrometer coupled with a splitless NanoLC-Ultra 2D Plus system (Eksigent, Dublin, CA, USA)28,30. This Nanoflex system uses a C18 desalting column (100 μm × 3 cm, 3 μm) and a ChromXP C18 (3 μm, 120 Å) packed separation column (75 μm × 15 cm). The desalted and loaded peptide solution was segregated using an elution gradient of 70-min at a 300-nl/min flow rate. The elution gradient began with a 5% mobile phase B (98% acetonitrile/0.1% formic acid) which progressed to 35%. Acquisition of MS data was carried out using an information-dependent acquisition (IDA) mode, where a mass range of 350–1,250 Da was scanned via a 250-ms IDA survey. After, 35 MS/MS scans of 100-ms at a 120 cps (counts/s) trigger with a +2 to +5 precursor charge state were carried out. A FWHM resolving power of 30,000 was used to conduct the MS scans, along with an 18 s dynamic exclusion time. Based on the charge-to-mass ratio of precursor ions, the optimal collision was computed empirically during the MS scan and the enhanced iTRAQ function was switched on to increase collision-induced dissociation efficiency.
Data analysis
AB SCIEX ProteinPilot software 4.5 with Paragon database search algorithm (4.5.0.0.1654) was employed for protein identification and iTRAQ quantitation28. The freely-available UniProt rat database released in July 2016 was imported for the search and it was merged with false discovery rate (FDR) analysis. The search parameters used included: sample type (eight-plex iTRAQ), digestion (trypsin), up to 2 missed cleavages, carbamidomethyl cysteine for fixed modification, methionine oxidation for variable modification, a peptide mass tolerance of ±20 ppm, 0.1 Da of fragment mass tolerance, TripleTOF 5600 instrument, and detailed ID for search effort. First, a 95% confidence was used to filter the peptides. Then, the ProGroup algorithm for redundancy minimization was used to group the proteins. Proteins were identified based on an unused protein score cutoff of ≥1.3, an FDR < 1%, two or more unique peptides with at least 95% confidence, or a single peptide with at least 99% confidence (Supplementary Table S2), as previously described31,32. Further, the relative quantity of a peptide across the diverse samples was assessed by comparing the intensities of reporter ion signals in the MS/MS scan. The protein ratios were computed from the average of all suitable isotope-tagged peptide ratios. A bias correction for the possible systematic error of unequal mixing in the different labeled samples was carried out based on the assumption that most proteins do not alter in expression. The software took the mean protein ratio and corrected it to unity. This is then applied to all quantification data. The data were exported into Excel for manual interpretation and then the protein ratios underwent a two-tailed Student’s t-test. Proteins with mean ratios of >1.2 and <0.83 and p-values of <0.05 were considered as significantly differentially expressed28. Following the data-sharing policy of the ProteomeXchange consortium, all raw and metadata have been deposited in the iProx submission system (http://www.iprox.org) and can be accessed with the identifier IPX0001464001.
Bioinformatics analysis
A multi-omics tool (OmicsBean) (http://www.omicsbean.cn) was employed for in silico analysis of the identified differentially expressed proteins33. The enrichment analyses of these proteins in biological process (BP), cellular component (CC), and molecular function (MF) were conducted based on the Gene Ontology (GO) terms of each protein. Further, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was employed and the pathways or GO terms with p-value <0.05 were considered significant34. Additionally, evaluation of protein–protein interactions was conducted with STRING database and visualized using Cytoscape software, as described previously33.
Immunoblot analysis
Immunoblots were conducted on hippocampal protein extracts according to our previously described procedure28,35. The primary antibodies used included: Esd (1:10,000; ab133631, Abcam), Idh2 (1:1,000; ab131263, Abcam), Dld (1:10,000; ab133551, Abcam), Sdha (1:1,000; ab137040, Abcam), G6pdx (1:1,000; ab210702, Abcam), Dlat (1:1,000; ab172617, Abcam), Pkm (1:1,000; C103A3, CST), Aldh2 (1:1,000; ab108306, Abcam), Glo1 (1:1,000; ab137098, Abcam), Ogdhl (1:500; 17110–1-AP, Proteintech), Anxal (1:2,000; ab214486, Abcam), Por (1:10,000; ab180597, Abcam), Prdx6 (1:1,000; ab133348, Abcam), Prnp (1:5,000; ab52604, Abcam), and Tpp2 (1:1,000; ab180177, Abcam). Anti-mouse or anti-rabbit horseradish peroxidase-conjugated IgG (1:10,000; Bio-Rad) was used as a secondary antibody. After gel electrophoresis and immunodetection, the protein band intensities were analyzed using Quantity One (Bio-Rad) software. Non-target protein bands in Coomassie blue-stained gels before being transferred to a PVDF membrane were used as the loading control28,36.
Statistical analysis
SPSS software was used for all statistical analysis10. One-way analyses of variance (ANOVA) followed by the post hoc least significant difference test was used to analyze the SPT, FST, EMT, body weight, and immunoblot data. P-values of <0.05 were considered statistically significant. All results were expressed as mean ± standard error.
Results
Behavioral assessment of CMS rats
We first performed the SPT and FST analysis to evaluate the depression-like behavior of CMS-exposed rats, thereby obtaining the depression-susceptible subgroup33. Through an eight-week CMS regime, rats displaying a significant reduction in sucrose preference were considered to be susceptible to CMS-induced depression33. As shown in Fig. 1a, the depression-susceptible group showed a significantly lower sucrose preference as compared with other groups over the 3-weeks and this difference remained significant through the last week. The FST result indicated higher immobility time for the depression-susceptible group at the end of the CMS procedure compared with the other groups (p < 0.01), suggesting that the despair-like behavior of CMS-exposed rats was correlated to anhedonia (Fig. 1b). Of note, some CMS rats did not exhibit depression-like behavior, but rather showed an anxiety-like behavior as indexed by the EMT, and could be considered to be susceptible to stress-induced anxiety7,37. It was observed that the anxiety-susceptible group entered fewer times and spent less time in the open arms of the maze when compared to the other groups (Fig. 1c, d). Furthermore, no significant differences in the SPT, FST, and EMT were observed among the control and insusceptible groups, which suggests that the insusceptible group did not have any depression-like and anxiety-like phenotypes. In addition, a gradual but significant increase in body weight in the controls was observed, almost over all weeks, compared with the stressed groups. However, there were no significant differences among the stressed groups (Supplementary Fig. S1). Taken together the behavioral data suggested that a subset of the control, depression-susceptible, and anxiety-susceptible group could be obtained, and the CMS paradigm described here might provide an effective tool for investigating disorder-specific molecular aspects especially the specific and general neural characteristics of non-comorbid depression and anxiety.
Quantitative proteomic analysis of the rat hippocampal proteins
In this study, changes in the hippocampus proteome of CMS-exposed rats were investigated via employing the previously established iTRAQ-based quantitative approach10,28. An outline of the iTRAQ-based quantitative workflow is displayed as Fig. 1e. For comparative proteomics analysis, four animals were used per group and the hippocampus tissues from two rats for each of these samples were pooled as described previously38. The whole proteins were effectively extracted using the SDT lysis buffer. Before proceeding with trypsin digestion and MS detection, a short gel-based approach was employed to eliminate SDS interference28,39. In the current study, a total of 2593 distinct proteins were identified and 2566 were quantified with less than 1% FDR (Supplementary Table S2). The efficiency of iTRAQ labeling was assessed to be about 97% as described previously. The proteome profiles of control, depression-susceptible, anxiety-susceptible, and insusceptible groups were comparatively analyzed to identify differentially expressed proteins. Proteins with p < 0.05 (student’s t-test) and a fold change >1.2 were considered significantly expressed. We identified 367 CMS-responsive proteins with these cut-offs (Supplementary Table S2).
Functional and network analysis of differential protein in CMS-induced rats
Differential proteomic analysis in the rat model revealed 52 up-regulated and 84 down-regulated proteins in the depression-susceptible group, 69 up-regulated and 76 down-regulated proteins in the anxiety-susceptible group, and 66 up-regulated and 111 down-regulated in the insusceptible group. We found 31 proteins with similar regulations in the two susceptible (depression and anxiety) groups, which may represent some common abnormal components between these two CMS-induced disorders. Among the insusceptible and the two susceptible groups, only 13 proteins were regulated similarly as a result of exposure to CMS (Fig. 2b). Interestingly, the association of 79% of these proteins among the three stressed groups, suggested that the molecular mechanisms underlying responses to stress are different among these groups. Further, unsupervised hierarchical clustering analysis of the 367 differentially expressed proteins clustered them into three distinct groups representing the three different responses to CMS (Fig. 2c).
To gain insights into the involvement of these proteins in different biological functions and pathways, these differentially expressed proteins in each CMS response group were analyzed with the OmicsBean tool33,34. GO analysis of the 136 differentially expressed proteins from the depression-susceptible group identified 768, 203, 222, and 33 terms to be significantly enriched (p < 0.05) in the biological process (BP), molecular function (MF), cellular component (CC), and KEGG pathway categories respectively (Supplementary Table S3). Figure 3a depicts the top ten enriched terms in the depression-susceptible group. Many proteins in the BP category were associated with docking, transport, and metabolic processes. CC category analysis showed that most of the proteins were predicted to be located in cytoplasm, vesicles, and mitochondria. MF analysis revealed that most of the proteins identified are involved in small molecule, protein, and nucleotide binding and catalytic activity. KEGG pathway enrichment indicated that the identified proteins are mainly involved in valine, leucine and isoleucine degradation, metabolic pathways, proximal tubule bicarbonate reclamation, cGMP-PKG signaling pathway, carbon metabolism, citrate cycle (TCA cycle), etc (Fig. 4a).
The 145 differentially expressed proteins from the anxiety-susceptible group were also categorized according to GO enrichment analysis, and 882, 210, 203, and 33 terms were identified to be significantly enriched (p < 0.05) in the BP, CC, MF, and KEGG pathway categories respectively. Figure 3b illustrates the top 10 enriched terms in the anxiety-susceptible group. The majority of proteins in the BP category are involved in the metabolic process of organonitrogen compounds, phosphorus, single-organism, organophosphate, purine ribonucleoside triphosphate, etc. CC category showed protein belonging to vesicle and cytoplasm parts, and MF indicated most protein to be involved in anion, small molecule, carbohydrate derivative, and nucleotide binding. KEGG pathway enrichment revealed these proteins to be linked with carbon metabolism, endocrine, and other factor-regulated calcium reabsorption pathways, Huntington's disease, pancreatic secretion, Parkinson's disease, etc (Fig. 4b).
GO enrichment analysis of the 177 differentially expressed proteins from the insusceptible group identified 1008, 231, 233, and 41 terms to be significantly enriched (p < 0.05) in the BP, CC, MF, and KEGG pathway categories respectively. Figure 3c shows the primary 10 enriched terms in the insusceptible group according to GO analysis. The majority of proteins in the BP category are involved in transport and localization. CC category indicated most proteins to be located in the cytoplasm and vesicle parts and MF category showed most proteins to be involved in protein, enzyme, anion, nucleotide binding, and catalytic activity. Pathway enrichment using KEGG revealed that these proteins were linked to pyruvate metabolism, valine, leucine and isoleucine degradation, pancreatic secretion, thyroid hormone synthesis, etc (Fig. 4c).
Interestingly, in the depression-susceptible group, 11 of 33 significantly enriched KEGG pathways were involved in the metabolic processes, which consisted of 7 up-regulated and 18 down-regulated proteins (Fig. 4a). Among the anxiety-susceptible group, 9 of 33 significantly enriched KEGG pathways were associated with metabolism, which consisted of 9 up-regulated and 9 down-regulated proteins. Between these two groups, there were some common and distinct pathways corresponding to significantly dysregulated proteins. Furthermore, we also found that 17 of 41 significantly enriched KEGG pathways in the insusceptible group were involved in the metabolic process, which consisted of 15 up-regulated and 18 down-regulated proteins. This indicated that metabolism-related pathways accounted for a relatively large proportion in the three stressed groups. Of note, despite similarity among the three groups, a significant number of metabolic pathways and corresponding proteins were noted, that were specifically associated to either depression-susceptible, anxiety-susceptible, or insusceptible groups, suggesting differences in the metabolic mechanisms underlying these three phenotypes (Supplementary Fig. S2 and Table S4). Subsequently, we further focused on the proteomics-inferred metabolic networks in the three CMS response groups (Fig. 4d, e). The significantly dysregulated proteins associated with the metabolic process were used in a protein–protein interaction (PPI) network analysis. By means of a unified conceptual framework, 25, 18, and 33 proteins were found to be key nodes in metabolism-related PPI networks from the depression-susceptible, anxiety-susceptible, and insusceptible groups respectively. These networks showed a close association between proteins and metabolic pathways and provided a small pool of metabolism-related interactome in stress susceptibility and resiliency, which may be relevant in future investigations.
Immunoblot detection of CMS-related mitochondrial and metabolic proteins
Altered mitochondrial and metabolic dysfunctions are generally believed to be important for stress-related disorders40,41. In this study, 15 proteins of interest involved in mitochondrial and metabolic pathways were selected for further expression validation by immunoblot to investigate their possible mechanisms. Overall, the immunoblot results mirrored the iTRAQ-based proteomics data (Supplementary Fig. S3). Further statistical analysis demonstrated that Por, Idh2, and Esd were significantly down-regulated in the depression-susceptible group as compared with the control group (Fig. 5). In the anxiety-susceptible group, Glo1, G6pdx, and Aldh2 were significantly down-regulated, while Dld was up-regulated, when compared to the control group. In the insusceptible group, Tpp2 was significantly down-regulated, while Dlat, Ogdhl, Anxal, and Sdha were up-regulated, when compared to the control group. Furthermore, Prnp and Pkm were significantly up-regulated in all three stressed groups as compared to the control group. For some of the proteins, the proteomics and immunoblot results showed discrepancies as reported in other proteomics studies42,43,44,45. Besides intrinsic differences between the two methods such as procedural steps and dynamic ranges42, another contributing factor might be the additional pooling procedure in the proteomics experiment46.
Discussion
The CMS procedure has been suggested to mimic socio-environmental stresses in inducing depression- and anxiety-related behaviors7,10,33,47,48. In our study, we identified three different stress-response phenotypes in the CMS rat model, mainly assessed by means of SPT, FST, and EMT7,10,33. Some rats exposed to CMS exhibited anhedonia-like behavior where their sucrose preferences were slower compared with the control. They also displayed a sign of behavioral depression, where the rats spent more time being immobile during the FST. Herein these rats were considered as susceptible to stress-induced depression. Furthermore, despite no deficit in the SPT and FST, some rats were more anxious, as they were less willing to stay or the open arms of the elevated plus maze. These rats could be considered as susceptible to stress-induced anxiety. It is noted that some animals did not exhibit depression- or anxiety-like behaviors and showed resiliency to developing these behaviors despite exposure to CMS. Overall, the CMS paradigm simulated realistic conditions for human depression and anxiety and generated several behavioral changes comparable to those witnessed clinically. This indicated that the molecular alterations identified using this rat model may also take place in human patients with stress-induced depression or anxiety. In our study, classification into depression-susceptible, anxiety-susceptible, and insusceptible cohorts provided a valuable approach in identifying common and distinct molecular bases of vulnerability to stress-induced depression or anxiety and stress resiliency. This CMS model can also provide valuable information for translational research.
We carried out iTRAQ-based quantitative proteomics followed by bioinformatics analysis to unravel the neurobiological underpinnings and identify phenotype-specific protein dysregulations in the hippocampi of the CMS rats exhibiting the three different behaviors. In total, 367 differentially expressed proteins were recognized from the hippocampi of depression-susceptible, anxiety-susceptible, and insusceptible groups as compared to the non-stressed controls. The proteins were that were altered similarly between the depression/anxiety-susceptible and insusceptible groups might serve as general functional components involved in the response to CMS. Those overlapping proteins between the depression-susceptible and anxiety-susceptible groups might underlie the common patterns of these two different disorders. Of note, proteins regulated uniquely in the three groups may underlie the observed behavioral differences. The heat map analysis also suggested that the three stressed groups displayed distinctive protein functional profiles. These results may help other researchers discover proteins and pathways associated with stress-induced depression or anxiety and stress resilience11.
Our proteomic data implicate affected pathways associated with stress-induced behaviors of depression, anxiety, and resilience in the hippocampus. KEGG pathway analysis indicated that these differentially expressed proteins were prevailingly involved in metabolic processes, such as the tricarboxylic acid (TCA) cycle, carbon, and pyruvate metabolism, oxidative phosphorylation, as well as other important metabolic processes. The regulatory network analysis revealed that protein-mediated metabolic processes as the common denominator may play a role in dysfunctional responses to stress41. These findings provide evidence that these metabolic mechanisms may also represent an important factor in the pathophysiological basis of stress. The 15 differentially expressed proteins involved in the metabolic process and selected for further validation with immunoblot indicated that Por, Idh2, and Esd were distinctly disregulated in the depression-susceptible group. Meanwhile, Glo1, G6pdx, Aldh2, and Dld were distinctly dysregulated in the anxiety-susceptible group. The specificity of the hippocampal molecular response suggests that similar CMS can influence the molecular processes differently, potentially prompting different biological repercussions in the hippocampus and correlative behavioral phenotypes in rats. Furthermore, Dlat, Ogdhl, Anxal, Tpp2, and Sdha were distinctly dysregulated in the insusceptible group, probably suggesting an important way to cope with the stress-induced metabolic dysfunctions in the hippocampus. It is tempting to speculate that these alterations may be involved in a stress protection mechanism in the rat hippocampus9.
In our present study, the 15 immune-detected proteins are mainly involved in TCA, carbon, and pyruvate metabolism. Among these proteins, we found that 8 proteins are predicted to be located in the mitochondria. In general, mitochondria are essentially involved in numerous metabolic processes, like metabolism of nucleic acid, protein, fat, and glucose40. Several pathogenic processes register mitochondrial dysfunction as the key cause including viral infection, autophagy, cell death, and metabolism49. Neuronal differentiation requires higher rates of mitochondrial biogenesis and thus impaired neuroplasticity could be a result of dysfunctional mitochondria in the hippocampus of depressed and anxious rats50,51,52. The mitochondrial and metabolic dysfunctions might be associated with the diminished plasticity of neurons and impaired neurogenesis of the hippocampal is considered to be operative during depression and anxiety, as neurogenesis is a process with enhanced metabolic demands53. Though we identified alterations in the expression of proteins involved in metabolic and mitochondrial dysfunctions in the hippocampus of the stressed rats, the detailed mechanisms behind such perturbations requires additional investigations.
Conclusion
Using iTRAQ-based quantitative proteomics to study alterations in the hippocampus of CMS-exposed rats identified several hippocampal protein candidates that might be associated with susceptibility to stress-induced depression or anxiety and stress resilience, and provided potential protein systems particularly involved in mitochondrial and metabolic pathways as new investigative protein targets. This offers novel insights into the regulatory mechanisms behind stress in CMS-exposed rats which may serve as the molecular basis for future research. This research can contribute to a better understanding of the similarities and differences of pathophysiologic mechanisms underlying stress-induced depression or anxiety and stress resiliency.
References
Almeida, O. P. et al. Anxiety, depression, and comorbid anxiety and depression: risk factors and outcome over two years. Int. Psychogeriatr. 24, 1622–1632 (2012).
Larson, C. L., Nitschke, J. B. & Davidson, R. J. Common and distinct patterns of affective response in dimensions of anxiety and depression. Emotion 7, 182–191 (2007).
Hamilton, J. P., Chen, M. C., Waugh, C. E., Joormann, J. & Gotlib, I. H. Distinctive and common neural underpinnings of major depression, social anxiety, and their comorbidity. Soc. Cogn. Affect. Neurosci. 10, 552–560 (2015).
Mathew, A. R., Pettit, J. W., Lewinsohn, P. M., Seeley, J. R. & Roberts, R. E. Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation? Psychol. Med. 41, 2023–2034 (2011).
Leuner, B. & Shors, T. J. Stress, anxiety, and dendritic spines: what are the connections? Neuroscience 251, 108–119 (2013).
Pittenger, C. & Duman, R. S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33, 88–109 (2008).
Chang, C. H. & Grace, A. A. Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats. Biol. Psychiatry 76, 223–230 (2014).
Yun, S. et al. Stress-induced anxiety- and depressive-like phenotype associated with transient reduction in neurogenesis in adult nestin-CreERT2/diphtheria toxin fragment a transgenic mice. PLoS ONE 11, e0147256 (2016).
Henningsen, K. et al. Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression. Mol. Cell. Proteom. 11, M111 016428 (2012).
Han, X. et al. iTRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depression. Neuroscience 298, 220–292 (2015).
Krishnan, V. et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391–404 (2007).
Melton, T. H., Croarkin, P. E., Strawn, J. R. & McClintock, S. M. Comorbid anxiety and depressive symptoms in children and adolescents: a systematic review and analysis. J. Psychiatr. Pract. 22, 84–98 (2016).
Brodbeck, J., Abbott, R. A., Goodyer, I. M. & Croudace, T. J. General and specific components of depression and anxiety in an adolescent population. BMC Psychiatry 11, 191 (2011).
Frick, A. Common and distinct gray matter alterations in social anxiety disorder and major depressive disorder. EBioMedicine 21, 53–54 (2017).
Zhao, Y. et al. Gray matter abnormalities in non-comorbid medication-naive patients with major depressive disorder or social anxiety disorder. EBioMedicine 21, 228–235 (2017).
Lotan, A. et al. Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders. Front. Neurosci. 8, 331 (2014).
Chen, J. J. et al. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders. Transl. Psychiatry 8, 192 (2018).
Pannekoek, J. N. et al. Investigating distinct and common abnormalities of resting-state functional connectivity in depression, anxiety, and their comorbid states. Eur. Neuropsychopharmacol. 25, 1933–1942 (2015).
Hill, A. S., Sahay, A. & Hen, R. Increasing adult hippocampal neurogenesis is sufficient to reduce anxiety and depression-like behaviors. Neuropsychopharmacology 40, 2368–2378 (2015).
van Tol, M. J. et al. Regional brain volume in depression and anxiety disorders. Arch. Gen. Psychiatry 67, 1002–1011 (2010).
McEwen, B. S., Eiland, L., Hunter, R. G. & Miller, M. M. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62, 3–12 (2012).
Bannerman, D. M. et al. Hippocampal synaptic plasticity, spatial memory and anxiety. Nat. Rev. Neurosci. 15, 181–192 (2014).
Curtiss, J. & Klemanski, D. H. Taxonicity and network structure of generalized anxiety disorder and major depressive disorder: an admixture analysis and complex network analysis. J. Affect. Disord. 199, 99–105 (2016).
Revest, J. M. et al. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol. Psychiatry 14, 959–967 (2009).
Desrosiers, A., Vine, V., Klemanski, D. H. & Nolen-Hoeksema, S. Mindfulness and emotion regulation in depression and anxiety: common and distinct mechanisms of action. Depress Anxiety 30, 654–661 (2013).
Wu, Y. et al. Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression. Behav. Brain Res. 311, 330–339 (2016).
Gouw, J. W., Krijgsveld, J. & Heck, A. J. Quantitative proteomics by metabolic labeling of model organisms. Mol. Cell. Proteom. 9, 11–24 (2010).
Zhou, M. et al. Quantitative proteomic analysis reveals synaptic dysfunction in the amygdala of rats susceptible to chronic mild stress. Neuroscience 376, 24–39 (2018).
Yeung, M., Lu, L., Hughes, A. M., Treit, D. & Dickson, C. T. FG7142, yohimbine, and betaCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta. Neuropharmacology 75, 47–52 (2013).
Zhou, M. et al. Effective lock-in strategy for proteomic analysis of corona complexes bound to amino-free ligands of gold nanoparticles. Nanoscale 10, 12413–12423 (2018).
Adav, S. S., Ravindran, A., Cheow, E. S. & Sze, S. K. Quantitative proteomic analysis of secretome of microbial consortium during saw dust utilization. J. Proteom. 75, 5590–5603 (2012).
Eagle, G. L. et al. Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia. Mol. Cell. Proteom. 14, 933–945 (2015).
Xie, H. et al. iTRAQ-based quantitative proteomics suggests synaptic mitochondrial dysfunction in the hippocampus of rats susceptible to chronic mild stress. Neurochem. Res. 43, 2372–2383 (2018).
Sun, N. et al. Proteomics analysis of cellular proteins co-immunoprecipitated with nucleoprotein of influenza A virus (H7N9). Int. J. Mol. Sci. 16, 25982–25998 (2015).
Qiao, R. et al. In-depth analysis of the synaptic plasma membrane proteome of small hippocampal slices using an integrated approach. Neuroscience 353, 119–132 (2017).
Tang, C. E. et al. Identification of the amyloid beta-protein precursor and cystatin C as novel epidermal growth factor receptor regulated secretory proteins in nasopharyngeal carcinoma by proteomics. J. Proteome Res. 9, 6101–6111 (2010).
Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322–328 (2007).
Lenselink, A. M. et al. Strain differences in presynaptic function: proteomics, ultrastructure, and physiology of hippocampal synapses in DBA/2J and C57Bl/6J mice. J. Biol. Chem. 290, 15635–15645 (2015).
Yu, H. et al. Development and application of wide-range gradient gel electrophoresis to proteome analysis. Anal. Methods 7, 8109–8115 (2015).
Allen, J., Romay-Tallon, R., Brymer, K. J., Caruncho, H. J. & Kalynchuk, L. E. Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front. Neurosci. 12, 386 (2018).
Filiou, M. D. et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol. Psychiatry 70, 1074–1082 (2011).
Abdi, F. et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 9, 293–348 (2006).
Kang, U. B. et al. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer 10, 114 (2010).
Cheng, P. J. et al. Differential proteomics analysis of amniotic fluid in pregnancies of increased nuchal translucency with normal karyotype. Prenat. Diagn. 31, 274–281 (2011).
Airoldi, L. et al. Effects of cigarette smoking on the human urinary proteome. Biochem. Biophys. Res. Commun. 381, 397–402 (2009).
Xu, H. B. et al. Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. Int. J. Neuropsychopharmacol. 15, 1413–1425 (2012).
Kim, M. H. & Leem, Y. H. Chronic exercise improves repeated restraint stress-induced anxiety and depression through 5HT1A receptor and cAMP signaling in hippocampus. J. Exerc. Nutr. Biochem. 18, 97–104 (2014).
Yue, N. et al. Electro-acupuncture alleviates chronic unpredictable stress-induced depressive- and anxiety-like behavior and hippocampal neuroinflammation in rat model of depression. Front. Mol. Neurosci. 11, 149 (2018).
Glombik, K. et al. The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression. Mol. Neurobiol. 53, 7351–7362 (2016).
Marazziti, D. et al. Mitochondrial alterations and neuropsychiatric disorders. Curr. Med. Chem. 18, 4715–4721 (2011).
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J. & Streck, E. L. Mitochondrial dysfunction and psychiatric disorders. Neurochem. Res. 34, 1021–1029 (2009).
Hollis, F. et al. Mitochondrial function in the brain links anxiety with social subordination. Proc. Natl Acad. Sci. USA 112, 15486–15491 (2015).
Streck, E. L. et al. Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders. Braz. J. Psychiatr. 36, 156–167 (2014).
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (Grants Nos. 31570826, 31770890).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tang, M., Huang, H., Li, S. et al. Hippocampal proteomic changes of susceptibility and resilience to depression or anxiety in a rat model of chronic mild stress. Transl Psychiatry 9, 260 (2019). https://doi.org/10.1038/s41398-019-0605-4
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-019-0605-4
- Springer Nature Limited
This article is cited by
-
Scopoletin mitigates maternal separation-induced anxiety-like and depression-like behaviors in male mice through modulation of the Sirt1/NF-κB pathway
Psychopharmacology (2024)
-
The Identification of Potential Anti-Depression/Anxiety Drug Targets by Stress-Induced Rat Brain Regional Proteome and Network Analyses
Neurochemical Research (2024)
-
Vilazodone Alleviates Neurogenesis-Induced Anxiety in the Chronic Unpredictable Mild Stress Female Rat Model: Role of Wnt/β-Catenin Signaling
Molecular Neurobiology (2024)
-
Lateralization of the 5-HT1A receptors in the basolateral amygdala in metabolic and anxiety responses to chronic restraint stress
Amino Acids (2024)
-
Changes in cognitive function, synaptic structure and protein expression after long-term exposure to 2.856 and 9.375 GHz microwaves
Cell Communication and Signaling (2023)